中金:首予時代中國(1233.HK)“跑贏行業”評級 目標價16.89港元
中金髮表研究報告指,時代中國(1233.HK)估值吸引,首次覆蓋並給予“跑贏行業”評級,目標價16.89港元,比昨日(14日)收市價13.08港元有29%的上行空間。
報告提及廣東省本土開發商時代中國的土儲超過90%位於粵港澳大灣區,土地儲備及潛在的城市更新項目足以覆蓋未來四年銷售。中金預計,對應兩年的年複合增速28%,公司2020年銷售額或超1000億元人民幣;核心淨利潤則對應兩年年複合增速26%,明年預計為67億元人民幣。同時,亦預計公司在手現金與銷售回款充裕以及外部融資能力較強,現金流具強韌性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.